# Regeneron Pharmaceuticals, Inc.: Form 8-K, filed Sep 8, 2023

- Company: [Regeneron Pharmaceuticals, Inc.](/companies/regn.md) (CIK 872589)
- Form: 8-K
- Filed: 2023-09-08
- Accepted by EDGAR: Sep 8, 2023, 16:52 ET
- Period: 2023-09-01
- Accession: 0001104659-23-099345
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/872589/000110465923099345/tm2325712d2_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/872589/000110465923099345/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/872589/000110465923099345/tm2325712d2_8k.htm

Filed Sep 8, 2023.
Source: SEC EDGAR, the filing index for accession 0001104659-23-099345. Last ingested by Listed: Oct 30, 2026, 16:29 ET. No prices; not investment advice.